FOR IMMEDIATE RELEASECredit: Elizabeth Cook FOR IMMEDIATE RELEASE A new drug for treatment of a type of brain cancer, called...
Boston – Vorasidenib has been approved by the U.S. Food and Drug Administration (FDA) for patients with Grade 2 gliomas...
Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is a protein receptor on T immune cells that prevents the cells from killing other...
*Note this is an early release from the Annual Meeting of the European Association of the Study of Diabetes (EASD...
By recruiting the immune system to combat tumor cells, immunotherapy has improved survival rates, offering hope to millions of cancer...
NEW YORK, NY (July 29, 2024) ---- Underrepresentation of racial and ethnic minority populations in cancer clinical trials persists partly...
How would you summarize your study for a lay audience? How would you summarize your study for a lay audience?...
Damon Runyon Cancer Research Foundation awards $5.2 million to top clinical investigators Damon Runyon Cancer Research Foundation awards $5.2 million...
Announcing a new article publication for BIO Integration journal. Cancer is a significant disease that poses a major threat to...
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Recent advancements in immunotherapy have substantially improved overall survival...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine